Invesco Biotechnology & Genome ETF
PBE
PBE
74 hedge funds and large institutions have $53.2M invested in Invesco Biotechnology & Genome ETF in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+5
Holders Change %
+7.25%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
22
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PSF
Pacific Sun Financial
Los Angeles,
California
|
+$639K |
2 |
Jane Street
New York
|
+$377K |
3 |
HighTower Advisors
Chicago,
Illinois
|
+$302K |
4 |
Morgan Stanley
New York
|
+$298K |
5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$205K |